查看购物车
  • Traditional Chinese
  • English
亚太地区体外诊断市场预测至 2030 年 - 区域分析 - 按产品和服务、技术、应用和最终用户
市场调查报告书
商品编码
1463560

亚太地区体外诊断市场预测至 2030 年 - 区域分析 - 按产品和服务、技术、应用和最终用户

Asia Pacific In-Vitro Diagnostics Market Forecast to 2030 - Regional Analysis - by Product & Services, Technology, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 121 Pages | 订单完成后即时交付

价格

亚太体外诊断市场预计将从2022年的191.0918亿美元成长到2030年的309.4327亿CAGR。

IVD 技术与数位健康解决方案的整合推动亚太体外诊断市场

IVD 用于临床、实验室和门诊环境，其具体目的是帮助检测疾病，从而帮助选择适当的治疗方案。 IVD 技术与数位健康解决方案的整合正在全球范围内受到关注。数据分析、人工智慧和远端监控增强了诊断测试的价值，从而实现更好的患者管理和结果。与数位健康解决方案整合的 IVD 技术可以纳入临床决策支援系统。正如世界卫生组织所认识到的，数位健康解决方案可以帮助检测疾病。人工智慧健康机器人和其他类似的新兴解决方案可能会为患者护理带来机会，并解决高成本和时间要求等挑战。在基于基因组测试的诊断中，深度学习可以识别癌细胞，确定其类型，并根据特定样本的图像预测肿瘤中可能发生哪些突变。体外诊断中的人工智慧和机器学习 (AI/ML) 正在彻底改变医疗设备的开发。这些现代诊断系统促进基于数位影像分析的诊断，从而改善医疗决策。智慧诊断是一种可扩展性极强的 IVD 解决方案，它使用人工智慧，其性能优于基于实验室的诊断，而价格仅为实验室诊断的一小部分。此外，这种类型的诊断可以透过独特的化学和生物特征检测和分析来得出新兴特征。因此，IVD 与数位健康技术的整合可能会在未来几年为体外诊断市场提供利润丰厚的机会。

亚太地区体外诊断市场概况

亚太地区体外诊断市场已细分为中国、日本、印度、澳洲、韩国和亚太地区其他地区。中国市场的成长很大程度上归功于疾病诊断意识的不断提高。由于全国疾病流行率较高，印度在体外诊断方面占据第三大份额。上述因素对亚太地区体外诊断市场的成长有重要影响。中国的癌症发生率和死亡率不断上升，这使得癌症成为过去十年中国的首要死因。大多数病例增加是由于人口增长（特别是老年人口激增）和社会人口变化造成的。临床试验实验室服务机构 Q2 Solutions 与广州金域诊断有限公司合作，为中国市场开发体外诊断产品和伴随诊断 (CDx)。此外，一些参与者正在投资扩大癌症生物标记市场。 2018 年 8 月，益普索 (Ipsos) 医疗保健服务线推出了联合实验室绘图研究和肿瘤分子诊断 (MDx) 监测器。这两项研究将在中国一二线城市提供全面的肿瘤生物标记测试。

亚太地区体外诊断市场收入及 2030 年预测（百万美元）

亚太地区体外诊断市场细分

亚太地区体外诊断市场分为产品和服务、技术、应用、最终用户和国家。

根据产品和服务，亚太体外诊断市场分为试剂和试剂盒、仪器以及软体和服务。 2022年，试剂和试剂盒细分市场在亚太体外诊断市场中占据最大份额。

根据技术，亚太体外诊断市场分为免疫分析/免疫化学、临床化学、分子诊断、微生物学、血糖自我监测、凝血止血、血液学、尿液分析等。 2022 年，免疫分析/免疫化学领域在亚太体外诊断市场中占据最大份额。

根据应用，亚太体外诊断市场分为传染病、糖尿病、肿瘤学、心臟病学、自体免疫疾病、肾臟病学等。 2022年，传染病领域在亚太体外诊断市场中占据最大份额。

根据最终用户，亚太体外诊断市场分为医院、实验室、家庭护理等。 2022年，医院细分市场在亚太体外诊断市场中占据最大份额。

依国家/地区划分，亚太地区体外诊断市场分为中国、日本、印度、澳洲、韩国和亚太地区其他地区。 2022年，中国将主导亚太体外诊断市场。

Abbott Laboratories、Becton Dickinson and Co、bioMerieux SA、Bio-Rad Laboratories Inc、Danaher Corp、F. Hoffmann-La Roche Ltd、Qiagen NV、Siemens AG 和 Thermo Fisher Scientific Inc 是亚太地区运营的一些领先公司体外诊断市场。

目录

第 1 章：简介

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：亚太地区体外诊断市场 - 主要产业动态

  • 主要市场驱动因素
    • 慢性病和传染病的盛行率不断增加
    • COVID-19 大流行期间床边检测的成长和 IVD 需求的激增
  • 市场约束
    • 监理框架和报销政策不足
  • 市场机会
    • IVD 与数位健康科技的整合
  • 未来的趋势
    • 对个人化医疗和基因组学的需求不断增长

第 5 章：亚太体外诊断市场 - 全球市场分析

  • 2022 - 2030 年亚太地区体外诊断市场收入

第 6 章：亚太地区体外诊断市场 - 收入和 2030 年预测 - 按产品和服务

  • 概述
  • 2022 年和 2030 年亚太地区体外诊断市场收入份额（按产品和服务划分）（%）
  • 试剂和试剂盒
  • 软体和服务
  • 仪器

第 7 章：亚太地区体外诊断市场 - 收入和 2030 年预测 - 按技术分类

  • 概述
  • 2022 年及 2030 年亚太地区体外诊断市场收入份额（按技术划分）（%）
  • 免疫测定/免疫化学
  • 临床化学
  • 分子诊断
  • 微生物学
  • 血糖自我监测
  • 凝血与止血
  • 血液学
  • 尿液分析
  • 其他的

第 8 章：亚太地区体外诊断市场 - 2030 年收入与预测 - 按应用

  • 概述
  • 2022 年及 2030 年亚太地区体外诊断市场收入份额，依应用划分 (%)
  • 传染病
  • 糖尿病
  • 肿瘤学
  • 心臟病学
  • 自体免疫疾病
  • 肾臟病学
  • 其他的

第 9 章：亚太地区体外诊断市场 - 收入和 2030 年预测 - 按最终用户

  • 概述
  • 2022 年及 2030 年亚太地区体外诊断市场收入份额（按最终用户划分）（%）
  • 医院
  • 实验室
  • 居家护理
  • 其他的

第 10 章：亚太地区体外诊断市场 - 2030 年收入与预测 - 国家分析

    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳洲
      • 韩国
      • 亚太地区其他地区

第 11 章：产业格局

  • 有机发展
    • 概述
  • 无机发展
    • 概述

第 12 章：公司简介

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Danaher Corp
  • Siemens AG
  • Thermo Fisher Scientific Inc
  • Becton Dickinson and Co
  • bioMerieux SA
  • Bio-Rad Laboratories Inc
  • Qiagen NV

第 13 章：附录

Product Code: TIPRE00022120

The Asia Pacific in-vitro diagnostics market is expected to grow from US$ 19,109.18 million in 2022 to US$ 30,943.27 million by 2030. It is estimated to grow at a CAGR of 6.2% from 2022 to 2030.

Integration of IVD Technologies with Digital Health Solutions Fuels Asia Pacific In-Vitro Diagnostics Market

IVD is used in clinical, laboratory, and outpatient settings with the aim specifically to help in the detection of diseases and, consequently, aid in the selection of appropriate treatment protocols. The integration of IVD technologies with digital health solutions is gaining traction globally. Data analytics, artificial Intelligence, and remote monitoring enhance the value of diagnostic tests, leading to better patient management and outcomes. IVD technologies integrated with digital health solutions can be incorporated into clinical decision support systems. As recognized by the WHO, digital health solutions could help detect diseases. Artificial intelligence health bots and similar other emerging solutions may present opportunities for patient care and address challenges such as high cost and time requirements. In diagnostics based on genomic testing, deep learning can identify cancer cells, determine their type, and predict what mutations may occur in a tumor from images of a specific sample. Artificial intelligence and machine learning (AI/ML) in in-vitro diagnostics are revolutionizing medical device development. These modern diagnostic systems facilitate diagnosis based on digital image analysis, thereby improving healthcare decision-making. Smart diagnostics are extremely scalable IVD solutions that use artificial intelligence to perform better than lab-based diagnostics at a fraction of the price. Additionally, this type of diagnostics can derive emergent features through unique chemical and biological signature detection and analysis. Thus, the integration of IVD with digital health technologies is likely to offer lucrative opportunities to the in-vitro diagnostics market in the coming years.

Asia Pacific In-Vitro Diagnostics Market Overview

The Asia Pacific in-vitro diagnostics market has been segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market growth in China is high attributed to the rising awareness of the disease diagnosis. India holds third largest share in terms of in-vitro diagnostics owing to high prevalence of diseases across the country. The aforementioned factors are responsible for influential growth of in-vitro diagnostics market in the Asia Pacific region. There has been a growth in cancer incidence and mortality rates in China, which has made cancer the primary cause of death in the last decade in the country. The majority of the increasing cases are due to population growth (particularly an upsurge in the elderly population) and socio-demographic changes. Q2 Solutions, a clinical trial laboratory services organization, collaborated with Guangzhou KingMed Diagnostics to develop in-vitro diagnostics products and companion diagnostics (CDx) for the Chinese market. Moreover, several players are investing in the expansion of the cancer biomarkers market. In August 2018, Ipsos' Healthcare Service Line launched the syndicated lab mapping study and oncology molecular diagnostics (MDx) monitor. These two studies will offer comprehensive oncology biomarker testing in China's tier I and tier II cities.

Asia Pacific In-Vitro Diagnostics Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific In-Vitro Diagnostics Market Segmentation

The Asia Pacific in-vitro diagnostics market is segmented into product & services, technology, application, end user, and country.

Based on product & services, the Asia Pacific in-vitro diagnostics market is segmented into reagents & kits, instruments, and software & services. The reagents & kits segment held the largest share of the Asia Pacific in-vitro diagnostics market in 2022.

Based on technology, the Asia Pacific in-vitro diagnostics market is segmented into immunoassay/ immunochemistry, clinical chemistry, molecular diagnostics, microbiology, blood glucose self-monitoring, coagulation & hemostasis, hematology, urinalysis, and others. The immunoassay/ immunochemistry segment held the largest share of the Asia Pacific in-vitro diagnostics market in 2022.

Based on application, the Asia Pacific in-vitro diagnostics market is segmented into infectious diseases, diabetes, oncology, cardiology, autoimmune diseases, nephrology, and others. The infectious diseases segment held the largest share of the Asia Pacific in-vitro diagnostics market in 2022.

Based on end user, the Asia Pacific in-vitro diagnostics market is segmented into hospitals, laboratories, homecare, and others. The hospitals segment held the largest share of the Asia Pacific in-vitro diagnostics market in 2022.

Based on country, the Asia Pacific in-vitro diagnostics market is segmented int o China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific in-vitro diagnostics market in 2022.

Abbott Laboratories, Becton Dickinson and Co, bioMerieux SA, Bio-Rad Laboratories Inc, Danaher Corp, F. Hoffmann-La Roche Ltd, Qiagen NV, Siemens AG, and Thermo Fisher Scientific Inc are some of the leading companies operating in the Asia Pacific in-vitro diagnostics market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific In-Vitro Diagnostics Market - Key Industry Dynamics

  • 4.1 Key Market Drivers
    • 4.1.1 Increasing Prevalence of Chronic and Infectious Diseases
    • 4.1.2 Growth in Point-of-Care Testing and Surge in Demand for IVD during COVID-19 Pandemic
  • 4.2 Market Restraint
    • 4.2.1 Insufficiency of Regulatory Frameworks and Reimbursement Policies
  • 4.3 Market Opportunities
    • 4.3.1 Integration of IVD with Digital Health Technologies
  • 4.4 Future Trends
    • 4.4.1 Increasing Demand for Personalized Medicine and Genomics

5. Asia Pacific In-Vitro Diagnostics Market - Global Market Analysis

  • 5.1 Asia Pacific In-Vitro Diagnostics Market Revenue (US$ Mn), 2022 - 2030

6. Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Product and Services

  • 6.1 Overview
  • 6.2 Asia Pacific In-Vitro Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
  • 6.3 Reagents and Kits
    • 6.3.1 Overview
    • 6.3.2 Reagents and Kits: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Software and Services
    • 6.4.1 Overview
    • 6.4.2 Software and Services: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Instruments
    • 6.5.1 Overview
    • 6.5.2 Instruments: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Technology

  • 7.1 Overview
  • 7.2 Asia Pacific In-Vitro Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
  • 7.3 Immunoassay/ Immunochemistry
    • 7.3.1 Overview
    • 7.3.2 Immunoassay/ Immunochemistry: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Clinical Chemistry
    • 7.4.1 Overview
    • 7.4.2 Clinical Chemistry: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Molecular Diagnostics
    • 7.5.1 Overview
    • 7.5.2 Molecular Diagnostics: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Microbiology
    • 7.6.1 Overview
    • 7.6.2 Microbiology: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Blood Glucose Self-Monitoring
    • 7.7.1 Overview
    • 7.7.2 Blood Glucose Self-Monitoring: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 Coagulation and Hemostasis
    • 7.8.1 Overview
    • 7.8.2 Coagulation and Hemostasis: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.9 Hematology
    • 7.9.1 Overview
    • 7.9.2 Hematology: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.10 Urinalysis
    • 7.10.1 Overview
    • 7.10.2 Urinalysis: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.11 Others
    • 7.11.1 Overview
    • 7.11.2 Others: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 Asia Pacific In-Vitro Diagnostics Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Infectious Disease
    • 8.3.1 Overview
    • 8.3.2 Infectious Diseases: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Diabetes
    • 8.4.1 Overview
    • 8.4.2 Diabetes: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Oncology
    • 8.5.1 Overview
    • 8.5.2 Oncology: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Cardiology
    • 8.6.1 Overview
    • 8.6.2 Cardiology: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Autoimmune Diseases
    • 8.7.1 Overview
    • 8.7.2 Autoimmune Diseases: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Nephrology
    • 8.8.1 Overview
    • 8.8.2 Nephrology: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.9 Others
    • 8.9.1 Overview
    • 8.9.2 Others: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 Asia Pacific In-Vitro Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Laboratories
    • 9.4.1 Overview
    • 9.4.2 Laboratories: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Homecare
    • 9.5.1 Overview
    • 9.5.2 Homecare: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - Country Analysis

  • 10.1 Asia Pacific In-Vitro Diagnostics Market
    • 10.1.1 Overview
    • 10.1.2 Asia Pacific: Asia Pacific In-Vitro Diagnostics Market, by Country
      • 10.1.2.1 China: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 China: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.1.3 China: Asia Pacific In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 10.1.2.1.4 China: Asia Pacific In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.2.1.5 China: Asia Pacific In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 10.1.2.1.6 China: Asia Pacific In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 10.1.2.2 Japan: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 Japan: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.2.3 Japan: Asia Pacific In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 10.1.2.2.4 Japan: Asia Pacific In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.2.2.5 Japan: Asia Pacific In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 10.1.2.2.6 Japan: Asia Pacific In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 10.1.2.3 India: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 India: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.3.3 India: Asia Pacific In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 10.1.2.3.4 India: Asia Pacific In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.2.3.5 India: Asia Pacific In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 10.1.2.3.6 India: Asia Pacific In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 10.1.2.4 Australia: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.4.1 Overview
        • 10.1.2.4.2 Australia: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.4.3 Australia: Asia Pacific In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 10.1.2.4.4 Australia: Asia Pacific In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.2.4.5 Australia: Asia Pacific In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 10.1.2.4.6 Australia: Asia Pacific In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 10.1.2.5 South Korea: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.5.1 Overview
        • 10.1.2.5.2 South Korea: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.5.3 South Korea: Asia Pacific In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 10.1.2.5.4 South Korea: Asia Pacific In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.2.5.5 South Korea: Asia Pacific In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 10.1.2.5.6 South Korea: Asia Pacific In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 10.1.2.6 Rest of Asia Pacific: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.6.1 Overview
        • 10.1.2.6.2 Rest of Asia Pacific: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.6.3 Rest of Asia Pacific: Asia Pacific In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 10.1.2.6.4 Rest of Asia Pacific: Asia Pacific In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.2.6.5 Rest of Asia Pacific: Asia Pacific In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 10.1.2.6.6 Rest of Asia Pacific: Asia Pacific In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)

11. Industry Landscape

  • 11.1 Organic Developments
    • 11.1.1 Overview
  • 11.2 Inorganic Developments
    • 11.2.1 Overview

12. Company Profiles

  • 12.1 Abbott Laboratories
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 F. Hoffmann-La Roche Ltd
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Danaher Corp
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Siemens AG
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Thermo Fisher Scientific Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Becton Dickinson and Co
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 bioMerieux SA
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Bio-Rad Laboratories Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Qiagen NV
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Asia Pacific In-Vitro Diagnostics Market Segmentation
  • Table 2. Death Rate Of Cancer in 2020 Globally
  • Table 3. China Asia Pacific In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. China Asia Pacific In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. China Asia Pacific In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. China Asia Pacific In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Japan Asia Pacific In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Japan Asia Pacific In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Japan Asia Pacific In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Japan Asia Pacific In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. India Asia Pacific In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. India Asia Pacific In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. India Asia Pacific In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. India Asia Pacific In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Australia Asia Pacific In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Australia Asia Pacific In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Australia Asia Pacific In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Australia Asia Pacific In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. South Korea Asia Pacific In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. South Korea Asia Pacific In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. South Korea Asia Pacific In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. South Korea Asia Pacific In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Rest of Asia Pacific Asia Pacific In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Rest of Asia Pacific Asia Pacific In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Rest of Asia Pacific Asia Pacific In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Rest of Asia Pacific Asia Pacific In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. Organic Developments Done by Companies
  • Table 28. Inorganic Developments Done by Companies
  • Table 29. Glossary of Terms, Asia Pacific In-Vitro Diagnostics Market

List Of Figures

  • Figure 1. Asia Pacific In-Vitro Diagnostics Market Segmentation, By Country
  • Figure 2. Asia Pacific In-Vitro Diagnostics Market: Key Industry Dynamics
  • Figure 3. Asia Pacific In-Vitro Diagnostics Market: Impact Analysis of Drivers and Restraints
  • Figure 4. Asia Pacific In-Vitro Diagnostics Market Revenue (US$ Mn), 2020 - 2030
  • Figure 5. Asia Pacific In-Vitro Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
  • Figure 6. Reagents and Kits: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Software and Services: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Instruments: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Asia Pacific In-Vitro Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 10. Immunoassay/ Immunochemistry: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Clinical Chemistry: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Molecular Diagnostics: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Microbiology: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Blood Glucose Self-Monitoring: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Coagulation and Hemostasis: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Hematology: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Urinalysis: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Others: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Asia Pacific In-Vitro Diagnostics Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 20. Infectious Diseases: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Diabetes: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Oncology: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Cardiology: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Autoimmune Diseases: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Nephrology: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Others: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Asia Pacific In-Vitro Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 28. Hospitals: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Laboratories: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. Homecare: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Others: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. Asia Pacific In-Vitro Diagnostics Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 33. Asia Pacific: Asia Pacific In-Vitro Diagnostics Market, by Country, 2022 & 2030 (%)
  • Figure 34. China: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 35. Japan: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 36. India: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 37. Australia: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 38. South Korea: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 39. Rest of Asia Pacific: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)